The role of WhatsApp™ in pediatric difficult airway management: A study from the PeDI Collaborative

BackgroundManagement of the pediatric difficult airway can present unique clinical challenges. The Pediatric Difficult Intubation Collaborative (PeDI‐C) is an international collaborative group engaging in quality improvement and research in children with difficult airways. The PeDI‐C established a W...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric anesthesia 2023-12, Vol.33 (12), p.1001-1011
Hauptverfasser: Pankiv, Evelina, Achaibar, Kira, Hossain, Alomgir, Fiadjoe, John E., Matava, Clyde T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundManagement of the pediatric difficult airway can present unique clinical challenges. The Pediatric Difficult Intubation Collaborative (PeDI‐C) is an international collaborative group engaging in quality improvement and research in children with difficult airways. The PeDI‐C established a WhatsApp™ group to facilitate real‐time discussions around the management of the difficult airway in pediatric patients. The goals of this study were to evaluate the patterns of use of the WhatsApp™ group, themes on messages posted on pediatric difficult airway management and to assess the perceived usefulness of the WhatsApp™ group by the PeDI‐C members.MethodFollowing research ethics approval, we performed a database analysis on the archived discussion of the PeDI‐C WhatsApp™ group from 2014 to 2019 and surveyed members to assess the perceived usefulness of the PeDI‐C WhatsApp™ group.Results5781 messages were reviewed with 350 (6.0%) original stems. The three most common original stem types were advice seeking 98 (28%), announcements 85 (24.2%), and clinical case‐sharing 78 (22.2%). The median number of responses to original stems was 9 [2–21.3]. Post types associated with increased responses included those seeking advice on medication/equipment (regression coefficient 0.78, 95% CI [0.41–1.16]; p 
ISSN:1155-5645
1460-9592
DOI:10.1111/pan.14760